South Korea's Daewoong Pharmaceutical sanctioned for filing fake patent infringement litigation
Daewoong Pharmaceutical was slapped with sanctions today by the South Korean antitrust regulator for abusing the patent infringement litigation system. The Korea Fair Trade Commission imposed a corrective order and a...To view the full article, register now.
Already a subscriber? Click here to view full article